切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2016, Vol. 05 ›› Issue (06) : 409 -412. doi: 10.3877/cma.j.issn.2095-3232.2016.06.015

所属专题: 文献

综述

Nrf2与肝脏缺血-再灌注损伤
刘荣强1, 汪国营1,()   
  1. 1. 510630 广州,中山大学附属第三医院器官移植中心
  • 收稿日期:2016-08-15 出版日期:2016-12-10
  • 通信作者: 汪国营
  • 基金资助:
    国家十二五科技重大专项(2012ZX10002017-005, 2012ZX10002016-023); 广东省科技计划项目(2014B020228003, 2014A020211015); 广东省自然科学基金(2015A030312013, 2015A030313038); 广州市科技计划项目(201400000001-3, 158100076, 2014J4100183)

Nrf2 and hepatic ischemia-reperfusion injury

Rongqiang Liu1, Guoying Wang1()   

  • Received:2016-08-15 Published:2016-12-10
  • Corresponding author: Guoying Wang
引用本文:

刘荣强, 汪国营. Nrf2与肝脏缺血-再灌注损伤[J]. 中华肝脏外科手术学电子杂志, 2016, 05(06): 409-412.

Rongqiang Liu, Guoying Wang. Nrf2 and hepatic ischemia-reperfusion injury[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2016, 05(06): 409-412.

[1]
Ferrari RS, Aandrade CF. Oxidative stress and lung ischemia-reperfusion injury[J]. Oxid Med Cell Longev, 2015:590987.
[2]
Shokeir AA, Barakat N, Hussein AM, et al. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study[J]. Physiol Res, 2015, 64(3):313-323.
[3]
Takagi T, Kitashoji A, Iwawaki T, et al. Temporal activation of Nrf2 in the penumbra and Nrf2 activator-mediated neuroprotection in ischemia-reperfusion injury[J]. Free Radic Biol Med, 2014(72):124-133.
[4]
Katsumata Y, Shinmura K, Sugiura Y, et al. Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2[J]. Hypertension, 2014, 63(1):80-87.
[5]
Tanaka Y, Maher JM, Chen C, et al. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice[J]. Mol Pharmacol, 2007, 71(3):817-825.
[6]
Moi P, Chan K, Asunis I, et al. Isolation of NF-E2-related factor 2(Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region [J]. Proc Natl Acad Sci U S A, 1994, 91(21):9926-9930.
[7]
Gao B, Doan A, Hybertson BM. The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders[J]. Clin Pharmacol, 2014(6):19-34.
[8]
Nioi P, Nguyen T, Sherratt PJ, et al. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation[J]. Mol Cell Biol, 2005, 25(24):10895-10906.
[9]
Wang H, Liu K, Geng M, et al. RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2[J]. Cancer Res, 2013, 73(10):3097-3108.
[10]
Wu J, Wang H, Tang X. Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha[J]. Biochem Biophys Res Commun, 2014, 452(3):554-559.
[11]
Namani A, Li Y, Wang XJ, et al. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer[J]. Biochim Biophys Acta, 2014, 1843(9):1875-1885.
[12]
Uruno A, Motohashi H. The Keap1-Nrf2 system as an in vivo sensor for electrophiles[J]. Nitric Oxide, 2011, 25(2):153-160.
[13]
Taguchi K, Fujikawa N, Komatsu M, et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis[J]. Proc Natl Acad Sci U S A, 2012, 109(34):13561-13566.
[14]
Ogborne RM, Rushworth SA, O'Connell MA. Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cdelta and Nrf2[J]. Biochem Biophys Res Commun, 2008, 373(4):584-588.
[15]
Ichihara S, Yamada Y, Liu F, et al. Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response[J]. Arterioscler Thromb Vasc Biol, 2010, 30(8):1553-1561.
[16]
Yu JB, Shi J, Zhang Y, et al. Electroacupuncture ameliorates acute renal injury in lipopolysaccharide-stimulated rabbits via induction of HO-1 through the PI3K/Akt/Nrf2 pathways[J]. PLoS One, 2015, 10(11):e0141622.
[17]
Ma Q, Battelli L, Hubbs AF. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2[J]. Am J Pathol, 2006, 168(6):1960-1974.
[18]
Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis[J]. J Clin Invest, 2006, 116(4):984-995.
[19]
Kong X, Thimmulappa R, Craciun F, et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis[J]. Am J Respir Crit Care Med, 2011, 184(8):928-938.
[20]
Morito N, Yoh K, Itoh K, et al. Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels[J]. Oncogene, 2003, 22(58):9275-9281.
[21]
Bhakkiyalakshmi E, Shalini D, Sekar TV, et al. Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2[J]. Br J Pharmacol, 2014, 171(7):1747-1757.
[22]
Luna-Vargas MP, Chipuk JE. The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane[J]. FEBS J, 2016, 283(14):2676-2689.
[23]
Lu YF, Liu J, Wu KC, et al. Overexpression of Nrf2 protects against microcystin-induced hepatotoxicity in mice[J]. PLoS One, 2014, 9(3):e93013.
[24]
Kode A, Rajendrasozhan S, Caito S, et al. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(3):L478-488.
[25]
Braun S, Hanselmann C, Gassmann MG, et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound[J]. Mol Cell Biol, 2002, 22(15):5492-5505.
[26]
Okouchi M, Okayama N, Alexander JS, et al. NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia-induced brain endothelial cell apoptosis[J]. Curr Neurovasc Res, 2006, 3(4):249-261.
[27]
Schaedler S, Krause J, Himmelsbach K, et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2[J]. J Biol Chem, 2010, 285(52):41074-41086.
[28]
Carvajal-Yepes M, Himmelsbach K, Schaedler S, et al. Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins[J]. J Biol Chem, 2011, 286(11):8941-8951.
[29]
Weigand K, Brost S, Steinebrunner N, et al. Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology[J]. HPB Surg, 2012:176723.
[30]
Kim HY, Kim SJ, Lee SM. Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion[J]. FEBS J, 2015, 282(2):259-270.
[31]
Leal AJ, Tannuri AC, Belon AR, et al. Effects of ischemic preconditioning in a pig model of large-for-size liver transplantation[J]. Clinics, 2015, 70(2):126-135.
[32]
Behrends M, Hirose R, Serkova NJ, et al. Mild hypothermia reduces the inflammatory response and hepatic ischemia/reperfusion injury in rats[J]. Liver Int, 2006, 26(6):734-741.
[33]
Kudoh K, Uchinami H, Yoshioka M, et al. Nrf2 activation protects the liver from ischemia/reperfusion injury in mice[J]. Ann Surg, 2014, 260(1):118-127.
[34]
Lee LY, Harberg C, Matkowskyj KA, et al. Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice[J]. Liver Transpl, 2016, 22(1):91-102.
[35]
Chi X, Zhang R, Shen N, et al. Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway[J]. Hepatol Int, 2015, 9(2):321-329.
[36]
Shimada S, Fukai M, Wakayama K, et al. Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver[J]. Surg Today, 2015, 45(7):892-903.
[37]
Joe Y, Zheng M, Kim HJ, et al. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309(1):G21-29.
[38]
Morales P, Vargas R, Videla LA, et al. Nrf2 activation in the liver of rats subjected to a preconditioning sub-chronic iron protocol[J]. Food Funct, 2014, 5(2):243-250.
[1] 李淼, 朱连华, 韩鹏, 姜波, 费翔. 高帧频超声造影评价肝细胞癌血管形态与风险因素的研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 911-915.
[2] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[3] 丁建民, 秦正义, 张翔, 周燕, 周洪雨, 王彦冬, 经翔. 超声造影与普美显磁共振成像对具有高危因素的≤3 cm肝结节进行LI-RADS分类诊断的前瞻性研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 930-938.
[4] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[5] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[6] 吕衡, 董理聪, 谢海琴, 赵卓非, 刘俐, 孙德胜. 基于CT-超声对照的肝脏局灶性病变超声漏诊状况分析:一项单中心横断面质量控制调查报告[J]. 中华医学超声杂志(电子版), 2023, 20(07): 712-716.
[7] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[8] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[9] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[10] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[11] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[12] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[13] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[14] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[15] 张大涯, 陈世锔, 陈润祥, 张晓冬, 李达, 白飞虎. 肠道微生物群对代谢相关脂肪性肝病发展的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 828-833.
阅读次数
全文


摘要